Additional uncommon somatic EGFR-mutations that have been detected in NSCLC patients displaying very rapid disease progression after initiation of first line TKI-treatment are the L747P substitution in exon 19 and short in-frame insertions/duplications in exon 20. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.